434 related articles for article (PubMed ID: 22723089)
1. Exosomes as biomarker enriched microvesicles: characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes.
Hosseini-Beheshti E; Pham S; Adomat H; Li N; Tomlinson Guns ES
Mol Cell Proteomics; 2012 Oct; 11(10):863-85. PubMed ID: 22723089
[TBL] [Abstract][Full Text] [Related]
2. Molecular lipidomics of exosomes released by PC-3 prostate cancer cells.
Llorente A; Skotland T; Sylvänne T; Kauhanen D; Róg T; Orłowski A; Vattulainen I; Ekroos K; Sandvig K
Biochim Biophys Acta; 2013 Jul; 1831(7):1302-9. PubMed ID: 24046871
[TBL] [Abstract][Full Text] [Related]
3. Exosomes confer pro-survival signals to alter the phenotype of prostate cells in their surrounding environment.
Hosseini-Beheshti E; Choi W; Weiswald LB; Kharmate G; Ghaffari M; Roshan-Moniri M; Hassona MD; Chan L; Chin MY; Tai IT; Rennie PS; Fazli L; Tomlinson Guns ES
Oncotarget; 2016 Mar; 7(12):14639-58. PubMed ID: 26840259
[TBL] [Abstract][Full Text] [Related]
4. Comparative Proteomic Analysis of Exosomes and Microvesicles in Human Saliva for Lung Cancer.
Sun Y; Huo C; Qiao Z; Shang Z; Uzzaman A; Liu S; Jiang X; Fan LY; Ji L; Guan X; Cao CX; Xiao H
J Proteome Res; 2018 Mar; 17(3):1101-1107. PubMed ID: 29397740
[TBL] [Abstract][Full Text] [Related]
5. Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer.
Duijvesz D; Burnum-Johnson KE; Gritsenko MA; Hoogland AM; Vredenbregt-van den Berg MS; Willemsen R; Luider T; Paša-Tolić L; Jenster G
PLoS One; 2013; 8(12):e82589. PubMed ID: 24391718
[TBL] [Abstract][Full Text] [Related]
6. Exosomal particles secreted by prostate cancer cells are potent mRNA and protein vehicles for the interference of tumor and tumor environment.
Rauschenberger L; Staar D; Thom K; Scharf C; Venz S; Homuth G; Schlüter R; Brandenburg LO; Ziegler P; Zimmermann U; Weitschies W; Völker U; Lendeckel U; Walther R; Burchardt M; Stope MB
Prostate; 2016 Mar; 76(4):409-24. PubMed ID: 26643154
[TBL] [Abstract][Full Text] [Related]
7. Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers.
Skotland T; Ekroos K; Kauhanen D; Simolin H; Seierstad T; Berge V; Sandvig K; Llorente A
Eur J Cancer; 2017 Jan; 70():122-132. PubMed ID: 27914242
[TBL] [Abstract][Full Text] [Related]
8. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
[TBL] [Abstract][Full Text] [Related]
9. The proteomics of prostate cancer exosomes.
Drake RR; Kislinger T
Expert Rev Proteomics; 2014 Apr; 11(2):167-77. PubMed ID: 24564711
[TBL] [Abstract][Full Text] [Related]
10. Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes.
Clark DJ; Fondrie WE; Yang A; Mao L
J Proteomics; 2016 Feb; 133():161-169. PubMed ID: 26739763
[TBL] [Abstract][Full Text] [Related]
11. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C
Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
[TBL] [Abstract][Full Text] [Related]
12. Prostate field cancerization and exosomes: Association between CD9, early growth response 1 and fatty acid synthase.
Amirrad F; Pytak PA; Sadeghiani-Pelar N; Nguyen JPT; Cauble EL; Jones AC; Bisoffi M
Int J Oncol; 2020 Apr; 56(4):957-968. PubMed ID: 32319557
[TBL] [Abstract][Full Text] [Related]
13. Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer.
Khan S; Jutzy JM; Valenzuela MM; Turay D; Aspe JR; Ashok A; Mirshahidi S; Mercola D; Lilly MB; Wall NR
PLoS One; 2012; 7(10):e46737. PubMed ID: 23091600
[TBL] [Abstract][Full Text] [Related]
14. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H
Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of microvesicles released by the human prostate cancer cell line PC-3.
Sandvig K; Llorente A
Mol Cell Proteomics; 2012 Jul; 11(7):M111.012914. PubMed ID: 22457534
[TBL] [Abstract][Full Text] [Related]
16. TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer.
Takayama K; Horie-Inoue K; Suzuki T; Urano T; Ikeda K; Fujimura T; Takahashi S; Homma Y; Ouchi Y; Inoue S
Mol Endocrinol; 2012 May; 26(5):748-61. PubMed ID: 22456197
[TBL] [Abstract][Full Text] [Related]
17. Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes.
Nimir M; Ma Y; Jeffreys SA; Opperman T; Young F; Khan T; Ding P; Chua W; Balakrishnar B; Cooper A; De Souza P; Becker TM
Cells; 2019 Jul; 8(7):. PubMed ID: 31288377
[TBL] [Abstract][Full Text] [Related]
18. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells.
Saari H; Lázaro-Ibáñez E; Viitala T; Vuorimaa-Laukkanen E; Siljander P; Yliperttula M
J Control Release; 2015 Dec; 220(Pt B):727-37. PubMed ID: 26390807
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer sheds the αvβ3 integrin in vivo through exosomes.
Krishn SR; Singh A; Bowler N; Duffy AN; Friedman A; Fedele C; Kurtoglu S; Tripathi SK; Wang K; Hawkins A; Sayeed A; Goswami CP; Thakur ML; Iozzo RV; Peiper SC; Kelly WK; Languino LR
Matrix Biol; 2019 Apr; 77():41-57. PubMed ID: 30098419
[TBL] [Abstract][Full Text] [Related]
20. BRD4 Regulates Metastatic Potential of Castration-Resistant Prostate Cancer through AHNAK.
Shafran JS; Andrieu GP; Györffy B; Denis GV
Mol Cancer Res; 2019 Aug; 17(8):1627-1638. PubMed ID: 31110158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
